Roderico H. Ofrin, WHO Representative to India, commended India's leadership in pharmacopoeial standard-setting and emphasised the importance of regulatory harmonisation in ensuring patient safety and ...

India is poised to capture a bigger share of the global pharmaceutical manufacturing market beyond generics, according to a ...

Sun Pharma appoints Aalok Shanghvi as COO, overseeing global operations and R&D, with expertise in emerging markets.

The Pharmaceutical R&D Outsourcing Market was valued at USD 84.01 billion in 2023, and is expected to reach USD 150.04 billion by 2029, rising at a CAGR of 10.15% The global pharmaceutical R&D ...

United Airlines has purchased all the capacity on a northbound cargo service from Puerto Rico to Chicago operated by Global ...

This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.

India on Wednesday reaffirmed its commitment to global pharmaceutical standardisation and regulatory convergence.

The Novo Nordisk Foundation does not plan to step in to prop up a global health sector reeling from a freeze on U.S.-funded ...

The Delhi High Court on February 3 passed an interim injunction restraining a pharmaceutical company from using the trademark ...

Sun Pharma's Q3FY25 net profit rose 15% YoY to ₹2,903 crore, driven by strong domestic and global specialty sales. Revenue ...

Hundreds of thousands of doses of moxidectin – which treats a disease caused by a parasitic worm – are being given to ...